Maryland Nursing Home Lawyer Blog

As Washington D.C. area nursing home lawyers, we have been following a recent lawsuit settlement, where a 94-year resident who lived in a convalescent home in Santa Clarita, California was awarded 12.5 million by a jury in punitive and compensatory damages for enduring nursing home abuse and sexual assault.

According to the lawsuit, Sophie Schwartz, a resident at Oakdale Heights facility who has dementia, was sexually assaulted by Jose Vazquez in her room on December 16, 2007. Vazquez was a dietary aid working at the facility, and was hired by Oakdale Heights Management Corporation, although he was allegedly an illegal immigrant.

The jury ruled that the corporation falsified certain documents relating to employment when hiring Vazquez, and also violated many California state laws that govern the quality of care for dementia residents in nursing homes that can lead to resident neglect, poor supervision, negligent in hiring practices and understaffing.

Vazquez allegedly had keys that gave him access to all of the resident’s room. According to the suit, his background check was not valid before being hired, and he had no training on how to deal with residents who were elderly. Vazquez was admittedly drunk at the time, and he claimed that he and other workers often drank on the job.

Continue reading "94-Year Old Sexual Assault Victim in Nursing Home Receives $12.5 Million" »

In recent national news that our Maryland-based Nursing Home Attorneys have been following, two nursing homes have settled in a wrongful death lawsuit, after the family of a resident sued the homes for not providing adequate care, and acting with nursing home negligence.

In the lawsuit, the family members of Ralph Seewald claimed that both Riverside Health Care Center and Village Health Care Center failed to provide proper care for the late-87-year old resident during his stay at the homes before his death in November 2005.

According to the suit, Seewald entered the Riverside Health Care Center in December 2004, with slight symptoms of dementia, and the plan for his care required two nursing home attendants to use a safety gain belt to assist him with all lifting and transfers to and from the wheelchair. Seewald was reportedly often transferred from the wheelchair by only one attendant with no gain belt, which reportedly lead to numerous falls.

Seewald allegedly suffered a fall while being transferred by only one attendant without a gain belt, from his wheelchair to the toilet on May 23, 2005, and broke his neck—leaving him bound to his bed. While immobile and bedridden, he developed serious decubitus ulcers, or pressure sores, that progressed rapidly during a few months, and led to a case of gangrene in his leg that allegedly caused his wrongful death.

Continue reading "Pressure Sores Lead to Wrongful Death—Nursing Homes Settles Suit with Family" »

As nursing home attorneys in the state of Maryland and the Washington D.C. area, we have been following the recent Britthaven of Chapel Hill Nursing Home investigation where Alzheimer’s patients have tested positive for serious pain-management prescription drugs that weren’t prescribed for them, and that they weren’t supposed to be receiving.

According to a recent news article, the North Carolina State Bureau of Investigation (SBI) and the Attorney General’s Medicaid Investigations Unit have launched a criminal investigation of the nursing home to determine if the patients were being over-medicated, abused or neglected, or being subjected to chemical restraint.

The investigation began after three Alzheimer’s patients from the nursing home were taken to local hospitals after nursing home staff claimed the patients were acting in an unusual manner. The hospital officials contacted the police, and the state Department of Health and Human Services, and officials from Britthaven after their blood tests showed strong drugs in their system that were not prescribed to them as patients.

The nursing home officials then reportedly tested all of the nearly 25 residents in the Alzheimer’s unit for drugs. Six of these patients tested positively for opiates, the drugs often used for pain management. Three of the patients were subsequently hospitalized, one of which died two days later.

Continue reading "State Investigates Nursing Home for Possible Negligence and Chemical Restraint" »

Our Maryland Nursing Home Attorneys have been following the recent story about a New York nursing home that is hoping to use new Israeli devices that can reportedly track wandering nursing home patients to maintain resident health and safety, and prevent nursing home falls or injury.

According to the article, the Hebrew Home, a prominent nursing home in New York, has been awarded a special legislation by New York State to try a new healthcare project, as part of the Managed Long-Term Care of the state.

The goal of the Hebrew Home’s CEO, Dan Reingold is to work with cutting edge technology companies and government officials in Israel to utilize innovative technologies, to find ways to maintain the health and safety of the residents, provide quality care, reduce nursing home falls with frail patients or patients experiencing dementia, and at the same time, cut nursing home costs. Reingold claims that the medical technology in Israel is far more advanced than technologies in the United States.

Some of the new technologies that are being developed focus on monitoring patients with devices that can keep track of how much time a person spends in bed, as well as monitoring patients who have a tendency to wander, and are at risk for falls or nursing home injury.

Continue reading "NY Nursing Home Looks to Israel Technology to Stop Resident Wandering and Falls" »

In yesterday’s blog, our Maryland Nursing Home Abuse Attorneys discussed the complaint filed last week by the U.S. Justice Department against Johnson & Johnson, for allegedly paying millions of dollars in kickback payments Omnicare, the largest pharmacy in the country, to increase sales of antipsychotic prescription drugs given to nursing home patients. According to the complaint, Omnicare was allegedly persuading physicians to prescribe drugs like the antipsychotic Risperdal for patients with dementia, even though the Food and Drug Administration has not approved the drug for dementia treatment.

In 1987, Congress passed landmark laws protecting patients from unnecessary drugs, and, according to these regulations, nursing home residents have the right to be protected from chemical restraints and medication for the sake of convenience or discipline to nursing home staff or doctors. It is illegal for facilities to give strong psychotropic drugs to patients without a doctor’s orders, patient’s consent and treatment justification, as patients may experience dangerous side effects like tremors, severe lethargy, nursing home falls, and wrongful death.

The Department of Health and Human Services states that nursing homes are required to have an outside pharmacist consult and review a patient’s medication schedule at least once a month. Once the outside pharmacist checks with the patient, they are obligated to report any oddities in the prescription drug schedule with the physician, and are able to make recommendations on how they would alter the medicine plan. But according to the complaint by the government, Johnson & Johnson used the consultant pharmacists as a tool to increase market share—dissolving the trust and integrity that should be a cornerstone for the health and safety of nursing home residents.

The New York Times reported this is not the first time that a drug company has been charged for using antipsychotic prescriptions to drug elderly residents. Eli Lilly pleaded guilty to a misdemeanor last January in a nearly $1.5 billion settlement of criminal and civil charges that the pharmaceutical company had marketed Zyprexa, the antipsychotic drug for the treatment of dementia with elderly people. Omnicare and Johnson & Johnson were reportedly trying to compete against AstraZenica’s antipsychotics, by increasing market share for Risperdal.

Continue reading " Nursing Home Residents Allegedly Drugged for Pharmacy Gain" »

In a recent nursing home injury blog, our Maryland-based attorneys discussed the epidemic of unnecessary drugging and chemical restraints going on in nursing homes, that can cause nursing home injury and threaten the lives of elderly residents.

Last week, the U.S. Justice Department filed a civil False Claims Act complaint against the drug giant Johnson & Johnson, for allegedly paying millions of dollars in kickback payments to a pharmacy company, in order to boost sales of antipsychotic prescription drugs for nursing home patients—drugs that can be used as chemical restraints with residents, that patients may or may not need.

The complaint alleges that from 1999—2004, pharmacists from Omnicare, the nation’s largest pharmacy, worked intensively to persuade physicians to prescribe Johnson & Johnson drugs in nursing homes, including the antipsychotic drug Risperdal, in exchange for kickback payments. The kickbacks were reportedly delivered to Omnicare in the form of rebates, grants, or educational funding.

Johnson & Johnson reportedly turned to Omnicare to increase the building of market share, knowing that physicians accepted advice on drugs from Omnicare pharmacists more than 80% of the time, and they were seen as an extension of the Johnson & Johnson workforce. The nursing home residents allegedly included people suffering from Alzheimer’s disease and dementia.

Continue reading "Johnson & Johnson Accused of Pharmacy Kickbacks" »

Our attorneys at Lebowitz and Mzhen, LLC, have recently read a study on nursing home residents with advanced dementia, published in the October 15, 2009, issue of The New England Journal of Medicine. According to the report, dementia is not just a disease of the mind, it is a physical illness as well—a leading cause of death in this country, and should be recognized as a terminal illness that requires high quality palliative care.

The report, led by Dr. Susan L. Mitchell from the Hebrew Senior Life Institute for Aging Research in Boston, studied 323 nursing home residents with advanced dementia and their families, in 22 different homes over a period of 18 months. The goal was to better understand the clinical complications of dementia and the families’ comprehension of the dementia prognosis, in order to make the right decisions in patient placement—reducing pain, suffering and nursing home injury and neglect in the final stages of life.

Patients with advanced dementia experience severe memory loss, have difficulty speaking, are restricted to the bed, and are totally dependent on others for care. The report argues that because dementia is consistently not recognized as a terminal illness, patients with advanced dementia are not being diagnosed as high risk for death, and are receiving poor palliative or nursing home care.

Mitchell argues that families need to clearly understand the prognosis of advanced dementia as a terminal illness, and the complications to expect, so patients can receive proper advanced care—like access to a high quality hospice, or improved skilled nursing home services. The goal, states the report, is to avoid patient suffering and pain, as well as nursing home negligence, due to lack of skilled nursing home services and supervision.

Continue reading "Advanced Dementia and Nursing Home Error" »